domingo, 18 de noviembre de 2018

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Main|Search|PHGKB

a crowd vs a few people

From National Institutes of Health Web Sites


No hay comentarios:

Publicar un comentario